DYNEX
GLOBAL

Mumps virus

Documents to download

Mumps virus


Order no.

 

Antibody specificity /
reagent / analyte

 
Ig 
class

 

Substrate

 

Species

 

Format

 

 EI 2630-9601 G

Mumps virus

IgG

 

2/20/200 RU/ml

96 x 01

EI 2630-9601 M
 
Mumps virus
incl. IgG/RF absorbent

 IgM  

semi-quantitative

96 x 01
 EI 2630-9601-3 G Mumps virus AT:
strains "Enders"
and "Jeryl Lynn"

IgG 


 

2/20/200 RU/ml

96 x 01
 EI 2630-9601-5 M Mumps virus G5: native antigens, genotype "G5"
incl. IgG/RF absorbent

IgM


semi-quantitative

96 x 01
 EI 2630-9601-L G Mumps virus antibody determination in CSF

IgG


  5/25/50/100 U 96 x 01
 FI 2630-1005 G
 FI 2630-1010 G
 FI 2630-1005 M
 FI 2630-1010 M
 FK 2630-1005
 FK 2630-1010
Mumps virus IgG


IgM
infected cells EU 13
10 x 05 (test system)
10 x 10 (test system)
10 x 05 (test system)
10 x 10 (test system)
 10 x 05 (single slides)
10 x 10 (single slides)
 FI 2822-1001-1 G
 FI 2822-1002-1 G
 FI 2822-1001-1 M *
 FI 2822-1002-1 M *
Exanthema Profile 1
(consisting of 21 different substrates)
IgG

IgM
field A: verification BIOCHIP,HHV-6,Rubella virus*, Measles virus,Mumps virus
field B: VZV, EBV-CA, EBV-EA, Treponema pallidum
field C: HSV-1 and -2, Coxsackie virus type B1 and A9
field D: Echo virus type 7, Borrelia afzelii, burgdorferi(CH),garinii
field E: CMV, Candida albicans,krusei*,tropicalis*
  



10 x 01 (test system)
10 x 02 (test system)
10 x 01 (test system)
10 x 02 (test system)
 FI 2823-1001-1 G *
 FI 2823-1002-1 G *
 FI 2823-1001-1 M *
 FI 2823-1002-1 M *
Lymphadenitis Profile 1
(consisting of 21 different substrates)
IgG

IgM
field A: verification BIOCHIP, HIV-1* and 2*, HHV-6, Rubella virus*
field B: measles virus, Mumps virus,Adenovirus type 3,Parainfluenza virus type 1
field C: EBV-CA, EBV-EA, Toxoplasma gondii, Treponema pallidum
field D: HSV-1 and -2, CMV, Coxsackie virus type B5
field E: Coxsackie virus type A9, Bartonella henselae, Chlamydia
trachomatis and pneumoniae
 

10 x 01 (test system)
10 x 02 (test system)
10 x 01 (test system)
10 x 02 (test system)
 FI 2824-1001-1 G
 FI 2824-1002-1 G
 FI 2824-1001-1 M *
 FI 2824-1002-1 M *
Central Nervous System Profile 1 
(consisting of 21 different substrates)

IgG

IgM

field A: verification BIOCHIP, Rubella virus*, Measles virus, Mumps virus, VZV
field B: Adenovirus type 3, EBV-CA, Treponema pallidum, Toxoplasma gondii
field C: HSV-1 and -2, Coxsackie virus type B1 and A7
field D: Echo virus type 7, Borrelia afzelii, burgdorferi (CH), garinii
field E: CMV, Haemophilus influenzae*, Listeria
monocytogenes 1/2a and 4b
  10 x 01 (test system)
10 x 02 (test system)
10 x 01 (test system)
10 x 02 (test system)
 FI 2824-1001-1 G
 FI 2824-1002-1 G
 FI 2824-1001-1 M *
 FI 2824-1002-1 M *
Central Nervous System Profile 1
(consisting of 21 different substrates)
IgG

IgM
field A: verification BIOCHIP, Rubella virus*, Measles virus, Mumps virus, VZV
field B: Adenovirus type 3, EBV-CA,Treponema pallidum,Toxoplasma gondii
field C: HSV-1 and -2, Coxsackie virus type B1 and A7
field D: Echo virus type 7, Borr. afzelii,burgdorferi (CH), garinii
field E: CMV, Haemophilus influenzae*,Listeria monocytogenes 1/2a and 4b
  10 x 01 (test system)
10 x 02 (test system)
10 x 01 (test system)
10 x 02 (test system)
 FI 2825-1001-1 G
 FI 2825-1002-1 G
 FI 2825-1001-1 M
 FI 2825-1002-1 M
Myocarditis Profile 1
(consisting of 17 different substrates)
IgG

IgM
field A: verification BIOCHIP, Mumps virus, Adenovirus type 3, Influenza virus type A (H1N1 and H3N2)
field B: Influenza virus Typ B, Parainfluenza virus type 1 and 2,
Mycoplasma pneumoniae
field C: CMV, Coxsackie virus type B1 and A16, Echo virus type 7
field D: Borrelia afzelii, burgdorferi (CH),garinii, Chlamydia pneumoniae
  10 x 01 (test system)
10 x 02 (test system)
10 x 01 (test system)
10 x 02 (test system)

 CK 2630-0220-L G CSQ pair of controls
anti-Mumps virus (IgG)
IgG      2 x 2 ml, ready for use
 CI 2630-0101 G antibodies against Mumps virus 
IgG positive control
IgG      0.1 ml
 CI 2630-0101 Z Mumps virus
negative control
IgG, IgM      0.1 ml
 CI 2630-0101 M antibodies against Mumps virus 
IgM positive control
IgM      0.1 ml

*) Currently not available as IVD in the European Union.

Technical details about Mumps virus

Warranty Mumps virus

1 Mumps virus

2 Mumps virus

3 Mumps virus

4 Mumps virus

5 Mumps virus

6 Mumps virus

7 Mumps virus

8 Mumps virus

9 Mumps virus

10 Mumps virus

  • Producer: EUROIMMUN

Mumps virus


Order no.

 

Antibody specificity /
reagent / analyte

 
Ig 
class

 

Substrate

 

Species

 

Format

 

 EI 2630-9601 G

Mumps virus

IgG

 

2/20/200 RU/ml

96 x 01

EI 2630-9601 M
 
Mumps virus
incl. IgG/RF absorbent

 IgM  

semi-quantitative

96 x 01
 EI 2630-9601-3 G Mumps virus AT:
strains "Enders"
and "Jeryl Lynn"

IgG 


 

2/20/200 RU/ml

96 x 01
 EI 2630-9601-5 M Mumps virus G5: native antigens, genotype "G5"
incl. IgG/RF absorbent

IgM


semi-quantitative

96 x 01
 EI 2630-9601-L G Mumps virus antibody determination in CSF

IgG


  5/25/50/100 U 96 x 01
 FI 2630-1005 G
 FI 2630-1010 G
 FI 2630-1005 M
 FI 2630-1010 M
 FK 2630-1005
 FK 2630-1010
Mumps virus IgG


IgM
infected cells EU 13
10 x 05 (test system)
10 x 10 (test system)
10 x 05 (test system)
10 x 10 (test system)
 10 x 05 (single slides)
10 x 10 (single slides)
 FI 2822-1001-1 G
 FI 2822-1002-1 G
 FI 2822-1001-1 M *
 FI 2822-1002-1 M *
Exanthema Profile 1
(consisting of 21 different substrates)
IgG

IgM
field A: verification BIOCHIP,HHV-6,Rubella virus*, Measles virus,Mumps virus
field B: VZV, EBV-CA, EBV-EA, Treponema pallidum
field C: HSV-1 and -2, Coxsackie virus type B1 and A9
field D: Echo virus type 7, Borrelia afzelii, burgdorferi(CH),garinii
field E: CMV, Candida albicans,krusei*,tropicalis*
  



10 x 01 (test system)
10 x 02 (test system)
10 x 01 (test system)
10 x 02 (test system)
 FI 2823-1001-1 G *
 FI 2823-1002-1 G *
 FI 2823-1001-1 M *
 FI 2823-1002-1 M *
Lymphadenitis Profile 1
(consisting of 21 different substrates)
IgG

IgM
field A: verification BIOCHIP, HIV-1* and 2*, HHV-6, Rubella virus*
field B: measles virus, Mumps virus,Adenovirus type 3,Parainfluenza virus type 1
field C: EBV-CA, EBV-EA, Toxoplasma gondii, Treponema pallidum
field D: HSV-1 and -2, CMV, Coxsackie virus type B5
field E: Coxsackie virus type A9, Bartonella henselae, Chlamydia
trachomatis and pneumoniae
 

10 x 01 (test system)
10 x 02 (test system)
10 x 01 (test system)
10 x 02 (test system)
 FI 2824-1001-1 G
 FI 2824-1002-1 G
 FI 2824-1001-1 M *
 FI 2824-1002-1 M *
Central Nervous System Profile 1 
(consisting of 21 different substrates)

IgG

IgM

field A: verification BIOCHIP, Rubella virus*, Measles virus, Mumps virus, VZV
field B: Adenovirus type 3, EBV-CA, Treponema pallidum, Toxoplasma gondii
field C: HSV-1 and -2, Coxsackie virus type B1 and A7
field D: Echo virus type 7, Borrelia afzelii, burgdorferi (CH), garinii
field E: CMV, Haemophilus influenzae*, Listeria
monocytogenes 1/2a and 4b
  10 x 01 (test system)
10 x 02 (test system)
10 x 01 (test system)
10 x 02 (test system)
 FI 2824-1001-1 G
 FI 2824-1002-1 G
 FI 2824-1001-1 M *
 FI 2824-1002-1 M *
Central Nervous System Profile 1
(consisting of 21 different substrates)
IgG

IgM
field A: verification BIOCHIP, Rubella virus*, Measles virus, Mumps virus, VZV
field B: Adenovirus type 3, EBV-CA,Treponema pallidum,Toxoplasma gondii
field C: HSV-1 and -2, Coxsackie virus type B1 and A7
field D: Echo virus type 7, Borr. afzelii,burgdorferi (CH), garinii
field E: CMV, Haemophilus influenzae*,Listeria monocytogenes 1/2a and 4b
  10 x 01 (test system)
10 x 02 (test system)
10 x 01 (test system)
10 x 02 (test system)
 FI 2825-1001-1 G
 FI 2825-1002-1 G
 FI 2825-1001-1 M
 FI 2825-1002-1 M
Myocarditis Profile 1
(consisting of 17 different substrates)
IgG

IgM
field A: verification BIOCHIP, Mumps virus, Adenovirus type 3, Influenza virus type A (H1N1 and H3N2)
field B: Influenza virus Typ B, Parainfluenza virus type 1 and 2,
Mycoplasma pneumoniae
field C: CMV, Coxsackie virus type B1 and A16, Echo virus type 7
field D: Borrelia afzelii, burgdorferi (CH),garinii, Chlamydia pneumoniae
  10 x 01 (test system)
10 x 02 (test system)
10 x 01 (test system)
10 x 02 (test system)

 CK 2630-0220-L G CSQ pair of controls
anti-Mumps virus (IgG)
IgG      2 x 2 ml, ready for use
 CI 2630-0101 G antibodies against Mumps virus 
IgG positive control
IgG      0.1 ml
 CI 2630-0101 Z Mumps virus
negative control
IgG, IgM      0.1 ml
 CI 2630-0101 M antibodies against Mumps virus 
IgM positive control
IgM      0.1 ml

*) Currently not available as IVD in the European Union.

  • Producer: EUROIMMUN
Dynex Dynex